Maria Natalia Gandur Quiroga: Key Findings from a Study on Intermediate-Risk Prostate Cancer

Maria Natalia Gandur Quiroga shared on X:

“Key Findings from a Study on Intermediate-Risk Prostate Cancer:
Active Surveillance Rising: Increased from 2% in 2010 to 8.6% in 2020

Favorable Intermediate Risk: Active surveillance grew from 2.4% to 13.5%

Unfavorable Intermediate Risk: Surveillance increased from 1.2% to 3.1%

Associated Factors: Older age, lower Gleason score, early T stage, treatment at academic centers.”

Source: Maria Natalia Gandur Quiroga/X

For more posts by María Natalia Gandur Quiroga, visit oncodaily.com

Maria Natalia Gandur Quiroga is a Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology at the Ángel H. Roffo Oncology Institute in Buenos Aires, Argentina. She is a Professor of Medicine at the University of Buenos Aires at the Oncologists Post Graduates Studies. Her research focuses on clinical trials with aims to improve the treatment of patients with urologic tumors.  She is an active member of the European Association for Cancer Research, Argentinian Medical Association and American Society of Clinical Oncology.